Search for: "Dur Corporation" Results 1 - 20 of 36
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Aug 2012, 7:46 pm by Lyle Denniston
   In the high-profile “K-Dur” case of Merck & Co., Inc., v. [read post]
17 Sep 2015, 6:22 am
We build upon the archival research by Sicard and extend the analysis of the archives of these early firms from the 16th through the 19th centuries in order to trace the evolution of corporate governance mechanisms over the “longue durée. [read post]
17 Sep 2015, 6:22 am
We build upon the archival research by Sicard and extend the analysis of the archives of these early firms from the 16th through the 19th centuries in order to trace the evolution of corporate governance mechanisms over the “longue durée. [read post]
23 May 2011, 1:54 pm by FDABlog HPM
(“Merck”) (formerly Schering-Plough Corporation) restricted competition in violation of the Sherman Act by settling patent infringement lawsuits against potential generic K-DUR entrants. [read post]
31 Jul 2012, 7:25 am by aschwartz
The plaintiffs are purchasers of K-Dur 20, a sustained-release potassium chloride tablet, and include plaintiffs CVS Pharmacy, Inc., Rite Aid Corporation, and Louisiana Wholesale Drug Company, Inc. [read post]
16 Jul 2012, 1:18 pm by Jeffrey May
The appellate court decided that wholesalers and retailers who purchased a brand-name sustained-release potassium chloride supplement (K-Dur) used to treat high blood pressure could proceed with an antitrust challenge  to patent infringement litigation settlement agreements between Schering-Plough Corporation — the manufacturer of K-Dur — and generic drug companies. [read post]
16 Jul 2012, 1:18 pm by Jeffrey May
The appellate court decided that wholesalers and retailers who purchased a brand-name sustained-release potassium chloride supplement (K-Dur) used to treat high blood pressure could proceed with an antitrust challenge  to patent infringement litigation settlement agreements between Schering-Plough Corporation — the manufacturer of K-Dur — and generic drug companies. [read post]
7 Aug 2012, 7:44 pm by Kevin Funnell
Dick Durbin, not content to shiv banks and credit unions in the back on debit card interchange fees (an act that prompted former FDIC Chairman Bill Isaac to label the Durbin amendment to the Dodd-Frank Act as ""pure and simple, special-interest politics" and "a terrible precedent") in order to serve his corporate masters, big box retailers like Wal-Mart and Target, now has his sights set on credit card companies. [read post]
2 Feb 2022, 4:00 am by Administrator
Driving Force Inc v I Spy-Eagle Eyes Safety Inc, 2022 ABCA 25 [64] While it is recognized that corporations can only act through their human agents, and often a corporate tort will involve those human agents, concurrent liability is not always appropriate. [read post]
25 Apr 2010, 5:52 pm by FDABlog HPM
(“Merck”) (formerly Schering-Plough Corporation) restricted competition in violation of the Sherman Act by settling patent infringement lawsuits against potential generic K-DUR entrants. [read post]
1 Feb 2015, 12:30 am by Emily Prifogle
There seemed little appetite to explore the longue durée, a term popularised in the 1950s by Fernand Braudel and other scholars associated with the French journal Annales. [read post]
22 Jan 2017, 6:57 pm by Daniel Shaviro
Biglaw does a great job of satirically yet horrifyingly conveying the NYC Biglaw corporate setting. [read post]
23 Jul 2018, 6:01 am
Black, Husein Bektic, Dan Davis, Iuri Struta, and Elana Duré. [read post]
4 Jan 2017, 4:00 am by Administrator
These persons employ a collection of techniques and arguments promoted and sold by ‘gurus’ (as hereafter defined) to disrupt court operations and to attempt to frustrate the legal rights of governments, corporations, and individuals. [read post]
27 Feb 2019, 6:04 am
Black, Elana Duré, Iuri Struta, Eleanor O’Donnell, Husein Bektic and Dan Davis. [read post]
15 Apr 2013, 9:44 am by Jack McNeill
”  (In re K-Dur Antitrust Litigation, 686 F.3d 197, 2012.) [read post]
27 Dec 2010, 11:28 am
Microsoft Corporation (ci-après «Microsoft»), a intenté l’action sous-jacente contre 276916 Ontario Ltd, une compagnie faisant affaires sous le nom de Smart Buy, et Samir Mohamed Jisri, son âme dirigeante pour violation de ses droits d’auteur. [read post]